David L. Kemmerly
Net Worth

Last updated:

What is David L. Kemmerly net worth?

The estimated net worth of Mr. David L. Kemmerly is at least $20,872,383 as of 29 Mar 2022. He owns shares worth $1,649,936 as insider, has earned $11,581,177 from insider trading and has received compensation worth at least $7,641,270 in Amedisys, Inc..

What is the salary of David L. Kemmerly?

Mr. David L. Kemmerly salary is $849,030 per year as Chief Legal & Gov. Affairs Officer in Amedisys, Inc..

How old is David L. Kemmerly?

Mr. David L. Kemmerly is 62 years old, born in 1963.

What stocks does David L. Kemmerly currently own?

As insider, Mr. David L. Kemmerly owns shares in one company:

Company Title Shares Price per share Total value
Amedisys, Inc. (AMED) Chief Legal & Gov. Affairs Officer 16,336 $101 $1,649,936

What does Amedisys, Inc. do?

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

David L. Kemmerly insider trading

Amedisys, Inc.

Mr. David L. Kemmerly has made 21 insider trades between 2016-2022, according to the Form 4 filled with the SEC. Most recently he sold 20 units of AMED stock worth $3,503 on 29 Mar 2022.

The largest trade he's ever made was exercising 23,437 units of AMED stock on 5 May 2020. As of 29 Mar 2022 he still owns at least 16,336 units of AMED stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 20 $175.16 $3,503
Sale
Common Stock 2,037 $177.21 $360,977
Sale
Common Stock 443 $177.89 $78,805
Sale
Common Stock 4,875 $290.12 $1,414,335
Option
Common Stock 3,125 $27.35 $85,469
Option
Stock Option (Right to Buy) 3,125 $27.35 $85,469
Sale
Common Stock 500 $280 $140,000
Sale
Common Stock 503 $270 $135,810
Option
Common Stock 3,396 N/A N/A
Option
Restricted Share Units (Performance-Based Vesting) 1,698 $295.2 $501,250
Sale
Common Stock 2,209 $176.63 $390,182
Option
Common Stock 23,437 $27.35 $641,002
Sale
Common Stock 23,437 $175.61 $4,115,654
Option
Stock Option (right to buy) 23,437 $27.35 $641,002
Sale
Common Stock 202 $191.88 $38,760
Sale
Common Stock 1,116 $156.99 $175,201
Option
Common Stock 725 $127.11 $92,155
Option
Stock Option (right to buy) 725 $127.11 $92,155
Option
Common Stock 5,292 N/A N/A
Option
Restricted Stock Unit (Performance-Based Vesting) 2,656 $198.81 $528,039
Option
Common Stock 8,125 $27.35 $222,219
Option
Stock Option (right to buy) 8,125 $27.35 $222,219
Sale
Common Stock 8,125 $117.77 $956,881
Sale
Common Stock 4,420 $113.4 $501,228
Sale
Common Stock 5,000 $113.48 $567,400
Option
Common Stock 5,000 $27.35 $136,750
Option
Stock Option (right to buy) 5,000 $27.35 $136,750
Option
Stock Option (right to buy) 5,000 $27.35 $136,750
Sale
Common Stock 5,000 $27.35 $136,750
Option
Common Stock 5,000 $27.35 $136,750
Sale
Common Stock 5,000 $115.25 $576,250
Option
Stock Option (right to buy) 5,000 $27.35 $136,750
Option
Common Stock 5,000 $27.35 $136,750
Sale
Common Stock 5,000 $118.75 $593,750
Option
Common Stock 5,000 $27.35 $136,750
Option
Stock Option (right to buy) 5,000 $27.35 $136,750
Option
Common Stock 3,125 $27.35 $85,469
Option
Restricted Stock Units 3,125 $27.35 $85,469
Sale
Common Stock 3,125 $27.35 $85,469
Option
Common Stock 3,125 $27.35 $85,469
Option
Stock Option (right to buy) 3,125 $27.35 $85,469
Sale
Common Stock 3,125 $116.82 $365,047
Option
Common Stock 3,125 $27.35 $85,469
Option
Stock Option (right to buy) 3,125 $27.35 $85,469
Option
Common Stock 3,125 $27.35 $85,469
Sale
Common Stock 3,125 $120.71 $377,219
Option
Stock Option (right to buy) 3,125 $27.35 $85,469
Option
Common Stock 3,375 $27.35 $92,306
Option
Stock Option (right to buy) 3,375 $27.35 $92,306
Sale
Common Stock 3,375 $27.35 $92,306
Sale
Common Stock 6,000 $79.28 $475,650
Option
Common Stock 6,000 $27.35 $164,100
Option
Stock Option (right to buy) 6,000 $27.35 $164,100
Option
Restricted Stock Units 3,125 $27.35 $85,469
Option
Common Stock 3,125 $27.35 $85,469
Option
Restricted Stock Units 3,125 $27.35 $85,469
Option
Common Stock 3,125 $27.35 $85,469
Option
Common Stock 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A

Amedisys key executives

Amedisys, Inc. executives and other stock owners filed with the SEC: